×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
PR Newswire
Share this article. Share toX. Share this article ... TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.
25 months ago
Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non ...
BioSpace
CBN is then formed by decarboxylation of CBNA. The findings obtained at the lab are complementary to our previous results, indicating that some...
50 months ago
Wize Pharma enters into JV with Cannabics Pharmaceuticals
BioSpectrum Asia
Wize Pharma, an Israel based clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, has announced that...
58 months ago
CBG and CBC Kill Gastrointestinal Cancer Cells in Preliminary Study
Cannabis Business Times -
TEL AVIV, Israel and BETHESDA, Maryland, Jan. 27, 2020 /PRNewswire/PRESS RELEASE -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX),...
51 months ago
Israeli firms team up to create kits for growing medical cannabis at home
The Times of Israel
Cannabics Pharmaceuticals, a cannabis company based in the US and Israel that uses artificial intelligence and big data to develop...
68 months ago
Cannabics Pharma, NewCanna Strike Agreement To Research Anti-Tumor Effects Of Ancestral Colombian Strains
Benzinga
Cannabics Pharmaceuticals Inc. CNBX. , a cannabinoid medicine company focused on cancer and its side effects, announced it has signed an...
50 months ago
Cannabics Pharmaceuticals developing cannabinoid colon cancer treatment
Mugglehead Magazine
Cannabics Pharmaceuticals, a company that develops novel medicines from cannabinoids, announced Monday it developed a formulation to fight...
48 months ago
Novel cannabinoid formula could be used as a cancer treatment
European Pharmaceutical Review
The novel formulation, containing the cannabinoids CBDV and CBGA, will now be tested for clinical safety and anti-cancer activity efficacy.
48 months ago
Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
BioSpace
Reznik is part of the company's strategy to develop new psychedelic inspired medicines and therapies to address several mental health related...
31 months ago
Cannabics Pharmaceuticals' Drug Candidate RCC-33 Prolongs Survival Rate in Mice Inoculated with Human ...
PR Newswire
(OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, released today the concluding results of its in-...
37 months ago